文献速递眼底病与葡萄膜炎青光眼

年龄是非儿科人群中类固醇诱导性高眼压的危险因素

Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population.
PubMed 文献 · Br J Ophthalmol · 2020-02-18

该回顾性观察研究纳入455例(570眼)接受玻璃体内地塞米松植入剂注射的患者,按年龄分组比较眼压升高率。结果显示年龄越小眼压升高率越高,≤30岁组达42.9%,51-60岁组为14.9%。结论提示年轻患者(<51岁)使用类固醇时需谨慎。

要点

  • 年龄越小,玻璃体内地塞米松植入后眼压升高风险越高。
  • ≤30岁患者眼压升高率为42.9%,显著高于年长组。
  • 以51-60岁组为参照,≤30岁组OR为5.048(95%CI 1.436-17.747)。

核心结论

  • 使用类固醇后眼压不良升高的发生率在老年患者中显著低于年轻患者。
  • 因此对年轻患者(<51岁)处方类固醇时需要谨慎。

研究设计与样本

  • 回顾性观察研究,纳入接受玻璃体内地塞米松(DEX,Ozurdex)植入剂注射的患者455例、570眼。
  • 按年龄分为16-30、31-40、41-50、51-60、61-70、71-80和81-90岁共七组。
  • 在注射前及注射后1周、1、2、3、6和12个月测量眼压。

主要发现

  • 眼压升高率在≤30岁组为42.9%,31-40岁组为35.3%,41-50岁组为28.3%,51-60岁组为14.9%,61-70岁组为12.2%,71-80岁组为8.4%,81-90岁组为9.1%。
  • 无论采用何种眼压测量方式,眼压升高的发生率均随年龄降低而呈上升趋势。
  • 随着年龄组降低,OR呈现显著的阶梯式增加。

关键数值与推荐

  • 以51-60岁组为参照,≤30岁组OR为5.048(95%CI 1.436-17.747)。
  • 31-40岁组OR为3.671(95%CI 1.101-12.238)。
  • 41-50岁组OR为2.538(95%CI 1.043-6.178)。
  • 61-70岁组OR为0.947(95%CI 0.431-2.078)。
  • 71-80岁组OR为0.713(95%CI 0.312-1.626);81-90岁组OR为0.646(95%CI 0.137-3.048)。

临床怎么用

  • 对年轻患者(<51岁)处方类固醇时应谨慎,并加强眼压监测。
  • 玻璃体内地塞米松植入后应按计划随访眼压,尤其年轻患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: To evaluate the age-related risk of steroid-induced ocular hypertension by analysing intraocular pressure (IOP) changes after intravitreal dexamethasone (DEX, Ozurdex) implant injection. METHODS: A retrospective observational study was conducted among patients (n=455; 570 eyes) who had received DEX injection. IOP was measured prior to injection and after 1 week and 1, 2, 3, 6 and 12 months. Results were divided into seven categories based on patient age: 16-30, 31-40, 41-50, 51-60, 61-70, 71-80 and 81-90 years. The IOP elevation rate was compared among the groups. RESULTS: The IOP elevation rate was 42.9% in patients aged ≤30 years (35.3%, 28.3%, 14.9%, 12.2%, 8.4% and 9.1% in the 31-40, 41-50, 51-60, 61-70, 71-80 and 81-90 groups, respectively). Regardless of how IOP was measured, there was an increasing trend in the incidence of IOP elevation with decreasing age. Furthermore, there was a significant stepwise increase in the OR with decreasing age groups. After the 51-60 group was set as the reference point, the ORs (95% CIs) were 5.048 (1.436 to 17.747), 3.671 (1.101 to 12.238), 2.538 (1.043 to 6.178), 0.947 (0.431 to 2.078), 0.713 (0.312 to 1.626) and 0.646 (0.137 to 3.048) in the ≤30, 31-40, 41-50, 61-70, 71-80 and 81-90 groups, respectively. CONCLUSION: The rate of adverse elevations in IOP after steroid use was significantly lower in older patients than in younger patients. Therefore, caution is required when prescribing steroids to younger patients (<51 years).

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Choi W, Bae HW, Choi EY, et al. Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population. Br J Ophthalmol. 2020. PMID: 32071035. doi:10.1136/bjophthalmol-2019-314559

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。